Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-21-018116
Filing Date
2021-03-29
Accepted
2021-03-29 07:34:14
Documents
3
Period of Report
2021-03-29

Document Format Files

Seq Description Document Type Size
1 PROXY pre14a0321_gxacquisition.htm PRE 14A 576682
2 GRAPHIC tproxy_001.jpg GRAPHIC 949585
3 GRAPHIC tproxy_002.jpg GRAPHIC 615822
  Complete submission text file 0001213900-21-018116.txt   2671178
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Acquisition Corp. (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38914 | Film No.: 21779463
SIC: 2834 Pharmaceutical Preparations